What GLP-1 Actually Means
GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally produces after eating. It signals your brain that you are full, stimulates insulin when blood sugar rises, and slows gastric emptying so meals satisfy longer. GLP-1 receptor agonist medications mimic this hormone continuously, creating a sustained version of the natural fullness signal.
All GLP-1 Medications Available in Pakistan
Semaglutide: Ozempic and Sematide
Semaglutide is the most studied GLP-1 for weight loss in Pakistan. Branded Ozempic by Novo Nordisk costs approximately PKR 21,500 per month. Local generic Sematide by Ferozesons Pharma costs PKR 4,000 to 8,000 per month for equivalent doses. Both contain identical active molecules. For most Pakistani patients, Sematide is the appropriate starting choice.
Tirzepatide: Mounjaro
Tirzepatide activates both GLP-1 and GIP receptors simultaneously and produces stronger weight loss than semaglutide. Clinical trials show up to 20% body weight loss over 72 weeks. However, a single Mounjaro pen costs approximately PKR 195,000, placing it beyond most patients.
Liraglutide: Victoza
Available in Pakistan since 2016. Requires daily rather than weekly injection. Produces somewhat less weight loss than semaglutide. Remains valid, particularly for patients who respond better to daily dosing.
Dulaglutide: Trulicity
Once-weekly injection with a user-friendly autoinjector. Produces moderate weight loss and good glycemic control. Good option for patients who find other devices difficult.
▶ Semaglutide produces 14% body weight loss over 68 weeks in clinical trials
▶ Tirzepatide produces up to 20% body weight loss in the SURMOUNT trials
▶ Local generic semaglutide costs one-quarter the price of branded Ozempic
How GLP-1 Produces Weight Loss
The primary effect is appetite suppression. GLP-1 signals the brain's hypothalamus to reduce hunger. Most patients describe feeling genuinely not hungry rather than hungry but resisting eating. This qualitative difference makes sustainable eating dramatically easier. Secondary mechanisms include slowed gastric emptying, improved insulin sensitivity, and direct effects on visceral fat tissue.
Who Qualifies for GLP-1 in Pakistan
Your doctor will consider you appropriate for GLP-1 therapy if your BMI is above 27 with a weight-related condition (diabetes, hypertension, PCOS, fatty liver), or above 30 regardless of other conditions.
Contraindications: personal or family history of medullary thyroid cancer, multiple endocrine neoplasia syndrome type 2, history of pancreatitis, and pregnancy or breastfeeding.
The Dosing Process
All GLP-1 medications start on the lowest dose and increase slowly over weeks. Semaglutide starts at 0.25mg weekly for four weeks as a tolerance-building phase. Dose then increases to 0.5mg and potentially 1mg. Rushing dose increases is the primary cause of severe nausea.
Side Effects and Management
Nausea is most common, typically peaking at weeks two to four and significantly improving by week six. Eating smaller portions, avoiding fatty foods, and not lying down after eating all help. Serious but rare: pancreatitis, gallbladder problems. Report severe upper abdominal pain to your doctor immediately.
For GLP-1 treatment assessment and prescription in Pakistan, visit LupinLife Pakistan.
FAQ
Can I buy GLP-1 without a prescription in Pakistan?
Legally no. These require a prescription. Purchasing without one risks counterfeit products, which are a growing problem in Pakistan.
Will I regain weight after stopping GLP-1?
Most patients regain significant weight after stopping, particularly without strong lifestyle habits. Long-term use is often required for sustained benefit.
How long before appetite reduces on semaglutide?
Most patients notice reduced appetite within the first week, even at starting dose. Full effect develops over four to six weeks.
Is Sematide as good as Ozempic?
Yes. Both contain semaglutide as active ingredient. Clinical effect at equivalent doses is the same. The difference is brand pricing.
Can GLP-1 medication be combined with other diabetes drugs?
Yes, but requires medical supervision. Combining with insulin or sulfonylureas increases hypoglycemia risk and requires dose adjustment of existing medications.